What fetal kidney-related risk is associated with the naproxen component of Suvexx from week 20 of pregnancy onward?

From week 20 of pregnancy onward, naproxen in Suvexx may cause fetal renal dysfunction resulting in oligohydramnios, potentially shortly after treatment starts and usually reversible on stopping; during the third trimester, renal dysfunction may progress to renal failure.